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ABSTRACT We determined the orientation of a biotinylated version of the pore-forming peptide GALA (WEAALAEALAE-
ALAEHLAEALAEALEALAA) at pH 5.0 in large unilamellar phosphatidylcholine vesicles, using the enhancement of BODIPY-
avidin fluorescence subsequent to its irreversible binding to a biotin moiety. GALA and its variants were biotinylated at the N-
or C-terminus. BODIPY-avidin was either added externally or was pre-encapsulated in vesicles to assess the fraction of
liposome-bound biotinylated GALA that exposed its labeled terminus to the external or internal side of the bilayer, respec-
tively. Under conditions where most of the membrane-bound peptides were involved in transmembrane aggregates and
formed aqueous pores (at a lipid/bound peptide molar ratio of 2500/1), the head-to-tail (N- to C-terminus) orientation of the
membrane-inserted peptides was such that 3⁄4 of the peptides exposed their N-terminus on the inside of the vesicle and their
C-terminus on the outside. Under conditions resulting in reduced pore formation (at higher lipid/peptide molar ratios), we
observed an increase in the fraction of GALA termini exposed to the outside of the vesicle. These results are consistent with
a model (Parente et al., Biochemistry, 29:8720, 1990) that requires a critical number of peptides (M) in an aggregate to form
a transbilayer structure. When the peptides form an aggregate of size i, with i  M  4 to 6, the orientation of the peptides
is mostly parallel to the membrane surface, such that both termini of the biotinylated peptide are exposed to external
BODIPY-avidin. This BODIPY-avidin/biotin binding assay should be useful to determine the orientation of other membrane-
interacting molecules.
INTRODUCTION
Many organisms, including fungi, insects, amphibians and
humans, secrete peptides that exhibit antibacterial, hemo-
lytic, and tumoricidal activities by virtue of their capacity to
adopt an amphipathic -helical conformation when they
bind to lipid membranes. These peptides kill a target cell by
inducing permeabilization, disruption, or disintegration of
its cytoplasmic membrane (Cornut et al., 1993). It is gen-
erally accepted that they exert their cytotoxic activities
directly on the lipid matrix of the cell membranes (Boman
et al., 1994).
For most of these natural toxins, including magainins,
pardaxins, -toxin, melittin, and alamethicin, it has been
proposed that they permeabilize model lipid membranes by
forming transient or permanent multimeric pores (Schwarz
and Arbuzova, 1995; Matsuzaki et al., 1995, 1996, 1997a;
He et al., 1995, 1996; Ludtke et al., 1996; Rapaport et al.,
1996; Rex and Schwarz, 1998). However, particularly in the
case of melittin and cecropins, other processes have also
been suggested to explain bilayer permeabilization, such as
the perturbation of the lipid packing induced by a high
density of surface-adsorbed peptides (Vogel and Ja¨hnig,
1986; Benachir and Lafleur, 1995; Terwilliger et al., 1982;
Gazit et al., 1995). In that case, bilayer destabilization can
arise from the induction of a negative curvature strain that
increases the lipid tendency to adopt inverted phases, or
from a positive curvature strain that causes an expansion of
the bilayer interface (Terwilliger et al., 1982; Batenburg and
De Kriujff, 1988; Tytler et al., 1993; Epand et al., 1995).
Ion pores formed by natural amphipathic -helical pep-
tides are generally modeled as bundles of aligned -helices
that span the membrane with their hydrophilic sides lining
the pore lumen (Sansom, 1991; Cafiso, 1994; Shai, 1994;
He et al., 1996). Investigations with analogs of cytotoxic
peptides clarify the importance of peptide charge and the
role of particular amino acids or arrays of amino acids in the
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conformation, membrane-binding affinity, and pore-form-
ing abilities of these toxins (Shai, 1994; Brachais et al.,
1995; Matsuzaki et al., 1997b, Kaduk et al., 1997). The
importance of the helix length, hydrophobicity, and hydro-
phobic moment on the formation, structure, and function of
ion channels has also been investigated with model peptides
such as GALA (Subbarao et al., 1987; Parente et al.,
1990a,b; Nicol et al., 1996), LA-E-M2 peptides (Tomich,
1993), LS and LSU peptides (Lear et al., 1988, De Grado et
al., 1989), or peptide P (Spach et al., 1985).
The synthetic peptide GALA (WEAALAEALAEALAE-
HLAEALAEALEALAA), named GALA 30 in this study,
has been designed to undergo a pH-sensitive conformational
change (Subbarao et al., 1987) that results in about a 100-
fold increase in the apparent egg yolk lecithin (egg PC)
bilayer/water partition coefficient of the peptide at acidic
pH (Parente et al., 1990a). The membrane-interacting prop-
erties of GALA have been extensively documented (Sub-
barao et al., 1987, 1988; Parente et al., 1988, 1990a,b;
Goormaghtigh et al., 1991; Fattal et al., 1994; Nicol et al.,
1996). In aqueous solution at neutral pH, the formation of
an -helix is not favored because of the electrostatic repul-
sions between the glutamic acid residues. At pH 5.0, the
neutralization of these residues promotes the formation of
an amphipathic -helix and GALA binding to egg PC
bilayers (Subbarao et al., 1987; Parente et al., 1990a). In the
optimal pH range of 5.0 and below, GALA induces the
leakage of egg PC liposome-encapsulated ANTS/DPX and
the rapid flip-flop of membrane phospholipids at very low
ratios of membrane-bound peptides per vesicle (Subbarao et
al., 1987; Parente et al., 1990b; Fattal et al., 1994). In the
case of neutral egg PC or POPC liposomes at pH 5.0,
analysis by a mathematical model of the percent ANTS/
DPX leakage (Parente et al., 1990b; Nicol et al., 1996) and
the percent flip-flop of phospholipids (Fattal et al., 1994) as
a function of lipid/peptide molar ratio predicted that the
peptide aggregates in a quasi-irreversible fashion in the
bilayer. When an aggregate reaches a critical size of 10 
2 monomers, it forms a pore that induces ANTS/DPX
leakage and rapid phospholipid flip-flop (Parente et al.,
1990b; Fattal et al., 1994; Nicol et al., 1996). The addition
of the anionic phospholipid POPG (up to 66.6 mol%) to
POPC in the vesicles composition does not modify the
peptide efficiency to induce ANTS/DPX leakage at pH 5.0
(Nicol et al., 1996). However, the presence of membrane
cholesterol (Nicol et al., 1996) and modifications in the
structure of the phospholipids alter pore formation by
GALA. For all liposome compositions tested, we have
shown that no leakage of a vesicle-encapsulated fluorescent
dextran 3000 MW occurs at peptide concentrations inferior
or equal to the minimum concentration necessary for com-
plete ANTS/DPX leakage. Given the Stokes radius of the
dextran and the evolution of the pore size with the number
of peptides forming it, this result means that the pores are
restrained to less than 14 peptides in the range of lipid/
peptide ratios where ANTS/DPX leakage is monitored.
However, to obtain a more thorough description of the
GALA pore, structural information is required.
The position of individual peptides in a membrane at
equilibrium can be detected by spectroscopic techniques
such as solid-state NMR (Bechinger et al., 1991; Smith et
al., 1994), oriented circular dichroism (Wu et al., 1990;
Ludtke et al., 1994), attenuated total reflection/Fourier
transform infrared (Goormaghtigh et al., 1991; Lu¨neberg et
al., 1995), fluorescence (Matsuzaki et al., 1994) or EPR
(Barranger-Mathys and Cafiso, 1996). These methods can
reveal the degree of peptide insertion in the membrane,
depending on peptide sequence, lipid/peptide molar ratio,
membrane composition, ionic strength, pH, and level of
lipid hydration. Although the position of membrane-bound
peptides relative to the bilayer plane has been extensively
studied, the head-to-tail (N- to C-terminus) orientation of
the membrane-inserted peptides has not been as carefully
defined. The most widely assumed model, which is in
accord with the model for channel-forming proteins, has all
of the helices in a pore arranged with the helix dipoles
pointing in the same direction (parallel) (Sansom, 1991).
For voltage-dependent ion channels, the alignment of the
dipoles, in response to the presence of a transmembrane
potential, might stabilize the pore structure. For some pep-
tide sequences, the parallel assembly might also stabilize the
high energy packing of peptides by increasing the favorable
intermolecular interactions. However, the rationale for a
parallel organization is less evident in the case of synthetic
peptides with a simplified sequence such as GALA.
Fourier transform infrared studies on oriented egg PC
multibilayers showed that, at relatively low lipid/peptide
molar ratios (under conditions of extensive pore formation),
the principal axis of GALA amphipathic helix is oriented
perpendicular to the bilayer surface at pH 5.0 (Goormagh-
tigh et al., 1991). In the present study, we determined the
surface-adsorbed or transbilayer orientation of the peptide
as a function of the lipid/peptide molar ratio, and we eluci-
dated the head-to-tail (N- to C-terminus) orientation of the
transbilayer peptides in POPC vesicles at pH 5.0, by using
a modification of a BODIPY-avidin/biotin binding assay
(Emans et al., 1995).
The avidin/biotin system was used by Qiu et al. (1994,
1996) and Slatin et al. (1994) to show that the gating of
colicin Ia, a bacteriocidal protein that forms a voltage-
sensitive channel, is associated with the translocation across
the membrane of a segment of the protein of at least 68
residues. In these studies, site-directed mutagenesis was
followed by biotinylation of a series of unique sites on
colicin Ia. Biotinylated residues that translocated or inserted
upon channel opening in planar lipid membranes were iden-
tified by streptavidin binding to them on the cis side (side of
colicin Ia addition) in the closed state and streptavidin
binding impeding the channel opening. Residues that trans-
located upon channel closing were identified by streptavidin
binding to them on the trans side in the open state. In this
case, streptavidin binding resulted in interference with
channel closing.
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Recently, Emans et al. (1995) applied the enhanced flu-
orescence of a BODIPY-modified avidin upon its binding to
biotin to develop an in vivo endosome fusion assay. We
modified this BODIPY-avidin/biotin binding assay to re-
solve the orientation of GALA in POPC liposomes at pH
5.0. We attached biotin to either termini of GALA and used
its high affinity binding to a BODIPY-avidin to determine
the location of the labeled terminus of the membrane-bound
peptide, inside or outside the vesicle. Under conditions
where all membrane-bound GALA are involved in trans-
membrane aggregates (at a lipid/peptide molar ratio of
2500/1), 3⁄4 of the peptides expose their N-termini to the
inside of the vesicle and their C-termini to the outside,
whereas the rest of the peptides are oriented in the opposite
direction. Under conditions of reduced pore formation (at
high lipid/peptide molar ratios), there is an increase of the
external exposure of both ends of the peptide. Based upon
model calculations, we conclude that the surface aggregate
formed by GALA must attain a critical number of between
4 to 6 peptides before it inserts into the bilayer.
MATERIALS AND METHODS
Reagents
POPC in chloroform was purchased from Avanti Polar Lipids Inc. (Ala-
baster, AL). ANTS, DPX, Biotin-X/SE) and N-(biotinoyl)N-(iodoacetyl)
ethylenediamine were purchased from Molecular Probes (Eugene, OR).
Neutralite BODIPY-avidin (Biwersi et al., 1996) was a generous gift from
N. Emans, J. Biwersi, and A. S. Verkman (University of California, San
Francisco). D-Biotin was obtained from SIGMA (St. Louis, MO).
Vesicle preparation and sizing
Reverse-phase evaporation vesicles (REV) were prepared as described
previously (Szoka and Papahadjopoulos, 1978) in (i) 5 mM TES, 100 mM
KCl (pH 7.0) or in (ii) 5 mM TES, 12.5 mM ANTS, 45 mM DPX, 20 mM
KCl (pH 7.0). When BODIPY-avidin was encapsulated, the liposomes
were prepared in a 5 mM TES, 100 mM KCl (pH 7.0) buffer containing
41.5 M BODIPY-avidin, and the sonication time of the REV preparation
was 20 s. The vesicles were extruded five times through a 0.1-m poly-
carbonate membrane (Nucleopore Corp., Pleasanton, CA) with a hand-held
extrusion device (Avestin, Ottawa, Canada). When ANTS/DPX or
BODIPY-avidin were encapsulated in liposomes, a Sepharose 4-B column
(1  16 cm) was used to separate vesicles from unencapsulated material
with the elution buffer 5 mM TES, 100 mM KCl (pH 7.0). Lipid phos-
phorus was determined by a modification of the Bartlett (1959) method.
The size distribution of the POPC liposomes was determined by quasi-
elastic light scattering with a Coulter apparatus N4 and was typically
characterized by a number average of 115 nm in diameter and a standard
deviation of 20 nm.
Synthesis and biotinylation of GALA peptides
Peptides GALA 30, GALA 29CC, and GALA 31CC were synthesized with
an Applied Biosystems 430A peptide synthesizer using standard scale
F-moc chemistry and a procedure with double coupling of amino acids.
The synthesis of GALA 31CN was carried out by coupling a cysteine to the
resin-attached GALA 30 using small scale F-moc chemistry. Peptides were
cleaved from the resin (200 mg) with neat TFA (5 mL) in the presence of
water (250 L), phenol (375 mg), ethanedithiol (125 L), and thioanisole
(250 L). The free peptides were separated from the resin by filtration and
then precipitated from solution by addition of ether. The dried precipitates
were dissolved in a 5 mM TES, pH 8.0 solution containing urea (6 M),
chromatographed on a Sephadex G-10 column (1  20 cm) with the
elution buffer 5 mM TES, pH 8.0, and the peptide-containing fractions
were lyophilized. The resulting lyophilized powders were dissolved in a 5
mM TES, pH 8.0 solution containing urea (6 M) and purified by reverse-
phase high performance liquid chromatography (HPLC) on a Perkin-Elmer
instrument equipped with a Rainin Dynamax preparative C18 column,
using the following conditions: solvent system A, 0.1% TFA in water;
solvent system B, 0.1% TFA in acetonitrile; gradient, 0–48% B in 5 min,
followed by 48–72% B in 120 min, and 72–100% in 5 min, flow rate 1
mL/min. GALA 30, GALA 31CC and GALA 31CN eluted at 63–64% B.
In the case of GALA 29CC, the slowest part of the gradient was 43–67%
B instead of 48–72% B, and the peptide eluted at 58% B. Mass spectrom-
etry was used in the positive mode to characterize the molecular mass of
the purified peptides. Mass spectra were obtained on a PerSeptive Biosys-
tems (Framingham, MA) Voyager linear time-of-flight mass spectrometer.
Sample desorption/ionization was accomplished by matrix-assisted laser
desorption ionization (MALDI) (Hillenkamp et al., 1991) with a 337-nm
nitrogen laser, and data were recorded with a 500-MHz digitizer. Samples
were prepared by mixing an aqueous solution of peptide (1:4) with a 10
mg/mL solution of -cyano-4-hydroxycinnamic acid in 60% ethanol/40%
acetonitrile and allowing a one L droplet of the mixture to air-dry on the
sample plate. The instrument was externally calibrated using standard
peptides (bradykinin and ACTH 18–39), and the maximum error of mass
measurement of the analyte ions was estimated to be 2 Da. Based on the
singly-charged molecular ion (M  H) and the sodium ion (M  Na),
the molecular masses of GALA 30, GALA 29CC, GALA 31CC, and GALA
31CN are 3032.4, 2950.3, 3120.5, and 3134.3 Da, respectively. Based on
the peptide sequences, the expected masses are 3032, 2951, 3121, and 3135
Da, respectively.
We labeled the peptide GALA 30 and its variants with a biotin reagent
at the C- or N-terminus to determine the peptide orientation in POPC
liposomes at pH 5.0. For biotinylation of GALA 30 (yielding GALA(N)1),
the peptide was dissolved in a mixture of 0.1 M sodium bicarbonate pH 8.5
solution/ethyl alcohol 1/1 (v/v). Biotin-X/SE in DMF was added to the
stirred peptide solution at a biotin/peptide molar ratio of 6. After 3 h,
glycine was added to the solution at a glycine/biotin molar ratio of 8/1 to
stop the reaction. For biotinylation of GALA 29CC, GALA 31CC, and
GALA 31CN with N-(biotinoyl)N-(iodoacetyl)ethylenediamine (yielding
GALA(C)2, GALA(C)3, and GALA(N)2, respectively), the peptides were
dissolved in a 50 mM TES, pH 8.3 solution. N-(biotinoyl)N-(iodoacetyl)
ethylenediamine in a mixture of DMF/DMSO 1/1 (v/v) was added to the
stirred peptide solutions at a biotin/peptide molar ratio of 4.5. After 90 min
of continuous stirring in the dark, -mercaptoethanol was added to the
solutions at a -mercaptoethanol/biotin molar ratio of 8/1 to stop the
reactions. After biotinylation, the reaction mixtures were chromatographed
on a Sephadex G-10 column (1  20 cm) with the elution buffer 5 mM
TES, pH 8.0 to separate biotin-labeled and -unlabeled GALA from the low
molecular weight byproducts of the coupling reaction. Separation of the
biotin-labeled GALA from the unlabeled peptide was carried out by
reverse phase HPLC on a Perkin-Elmer instrument equipped with a Dy-
namax C18 column, using the following conditions: solvent system A, 0.1%
TFA in water; solvent system B, 0.1% TFA in acetonitrile; gradient,
0–54% B in 5 min, followed by 54–61% B in 40 min, 61–75% in 105 min,
and 75–100% in 5 min, flow rate 1 mL/min. GALA(N)1 eluted at 68% B,
whereas GALA(C)3 and GALA(N)2 eluted at 66% B. In the case of
GALA(C)2 the slowest part of the gradient was 56–70% B, instead of
61–75% B, and the peptide eluted at 62% B. Similar to the unlabeled
peptides, mass spectrometry was used in the positive mode to characterize
the molecular mass of the purified biotinylated peptides. Based on the
singly-charged molecular ion (M  H) and the sodium ion (M  Na),
the molecular masses of GALA(N)1, GALA(N)2, GALA(C)2, and GA-
LA(C)3 are 3371.3, 3462.7, 3277.6, and 3448.8 Da, respectively. Based on
the peptide sequences, the expected masses are 3372 (3032  340), 3462
(3135  327), 3278 (2951  327), and 3448 (3121  327), respectively.
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Fluorescence measurements
Measurements were made on a Spex Fluorolog photon counting instrument
(Edison, NJ) under the control of an IBM PC equipped with DM3000
software, using a 150-W xenon light source, as previously described
(Parente et al., 1990a).
Measurements of ANTS/DPX leakage
The ANTS/DPX assay (Ellens et al., 1984) was used to measure the ability
of the GALA peptides to induce leakage of ANTS/DPX pre-encapsulated
in POPC liposomes. Details of this assay can be found in Nicol et al.
(1996). To initiate a leakage experiment, a few microliters of a 5 mM TES,
50 mM KCl, pH 8.0 solution containing a GALA peptide was added to a
stirred POPC vesicles suspension (0.1 mM lipid) at 20°C in a buffer at pH
5.0 containing 5 mM sodium acetate and 100 mM KCl, to achieve the
stated lipid/peptide molar ratio.
BODIPY-avidin/biotin binding assays
The BODIPY-avidin/biotin binding assay developed by Emans et al.
(1995) is based on the enhancement of the green fluorescence of a
BODIPY-modified avidin upon its quasi-irreversible binding to d-biotin.
To determine GALA surface-adsorbed or transbilayer orientation as well as
the head-to-tail (N- to C-terminus) orientation of the transbilayer peptides
in POPC liposomes at pH 5.0, we used the differential enhancement of
BODIPY-avidin fluorescence upon its binding to d-biotin or to a biotin-
ylated GALA peptide. In all measurements, we monitored the fluorescence
of BODIPY-avidin at   510 nm (2.5 mm slits), with the sample being
irradiated at   480 nm (1.25 mm slits).
Determination of external accessibility of
biotinylated peptide by external addition of
BODIPY-avidin
The purpose of the assay was to estimate R, the fraction of POPC liposome-
bound biotinylated GALA that expose their labeled termini (N or C) on the
external side of the vesicles at pH 5.0. The assay is illustrated in Fig. 1 and
required the measurement of three fluorescence intensities at the wave-
length corresponding to maximum emission of BODIPY (  510 nm).
Based on these intensities and a refinement procedure, we could determine
the fraction of POPC liposome-bound biotinylated GALA that bound to
BODIPY-avidin after addition of the protein to the liposome/peptide so-
lution at pH 5.0, which corresponded to R.
The measurement of the first fluorescence intensity required for the
computation of R, denoted “external layer exposure,” started with the
FIGURE 1 Illustration of the three independent measurements performed to obtain the three fluorescence intensities F0, F, and F100 required to calculate
r ( R/Z).
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addition of an aliquot of a 3 mM TES, 50 mM KCl (pH 8.0) buffer
containing a mixture of GALA 30 and a biotinylated GALA (typically at
a molar ratio of 19/1) to a stirred 2.5 mL vesicle suspension (2.5 mM
POPC) at 20°C in a 25 mM TES, 80 mM KCl (pH 5.0) buffer. With the
lipid concentration used (2.5 mM), all the added peptide bound to the
vesicles (Nicol et al., 1996). Peptides aggregated in the liposome bilayer to
form pores. After 15 min, an aliquot of a BODIPY-avidin solution con-
taining 3 mM TES and 100 mM KCl (pH 7.5) was added to the peptide/
liposome solution, typically at a BODIPY-avidin/biotinylated peptide mo-
lar ratio of 2, unless otherwise specified. At this point of the experiment,
the pH of the solution remained at 5.0. Every biotinylated GALA that
exposed its labeled terminus to the external side of the vesicle bound to a
BODIPY-avidin. After 15 min, d-biotin was added to the solution at a
d-biotin/BODIPY-avidin molar ratio of 16/1. Consequently, d-biotin satu-
rated the BODIPY-avidin binding sites that were unoccupied by the bio-
tinylated GALA. Finally, the pH of the solution was elevated to 8.0 by
adding 200 L of a 0.5 M TES pH 8.5 solution, which resulted in
dissociation of GALA from the liposomes (Parente et al., 1990b). The
fluorescence intensity, F, was recorded 3 min after the pH increase.
For the measurement of the second fluorescence intensity required to
compute the percent exposure, denoted control “pH-dissociation expo-
sure,” the addition of the peptide mixture to the liposome suspension and
the subsequent addition of BODIPY-avidin were identical to the first
measurement. Fifteen minutes after the addition of BODIPY-avidin, the pH
of the solution was elevated to 8.0 by adding 200 L of a 0.5 M TES pH
8.5 solution, which dissociated the peptides from the vesicles. At this point,
the biotinylated peptides that were dissociated to the external solution (as
opposed to the ones that were released on the inside of the vesicles) bound
to a BODIPY-avidin binding site. After 3 min, d-biotin was added to the
solution to establish a d-biotin/BODIPY-avidin molar ratio of 16/1. Again,
d-biotin saturated the unoccupied BODIPY-avidin binding sites. The flu-
orescence intensity, F100, was recorded 3 min after the addition of
d-biotin.
For the measurement of the third fluorescence intensity needed for the
computation, denoted control “no exposure,” the protocol was identical to
that of the external layer exposure measurement, except that the peptide
mixture consisted exclusively of nonbiotinylated GALA 30 at the same
total peptide concentration. The fluorescence intensity, F0, was recorded 3
min after the pH elevation.
In Eq. 1, let Fd be the BODIPY-avidin fluorescence at pH 8.0 when all
the BODIPY-avidin molecules have their binding sites saturated with
d-biotin.
F0 Fd A, (1)
in which A is a constant term arising essentially from the contribution of
the liposomes and the buffer. Let FGd denote the BODIPY-avidin fluores-
cence at pH 8.0 that would arise if all BODIPY-avidin molecules had three
of their four binding sites occupied by d-biotin and the last one occupied
by a biotinylated GALA. Let X be the fraction of BODIPY-avidin at the
end of the control pH-dissociation exposure that had its binding sites
occupied in such a pattern (3 d-biotins/1 biotinylated GALA). If we assume
that, because of the excess of BODIPY-avidin, each BODIPY-avidin
molecule bound, at most, one biotinylated GALA in the control pH-
dissociation exposure, then
F100 XFGd 	1	 X
Fd A, (2)
where F denotes the measured fluorescence intensity at the end of the
control pH-dissociation exposure.
Let r denote the fraction of biotinylated GALA bound to BODIPY-
avidin in the external layer exposure measurement (R) divided by the
fraction of biotinylated GALA bound to BODIPY-avidin in the control
pH-dissociation exposure (Z, the labeled peptides that were dissociated on
the outside of the liposomes after the pH increase to 8.0). If we assume that
each BODIPY-avidin molecule bound, at most, one biotinylated GALA in
the external layer exposure measurement, then
F rXFGd 	1	 rX
Fd A, (3)
where F denotes the measured fluorescence intensity at the end of the
external layer exposure measurement. The combination of Eqs. 1–3 yields
r 	F0	 F
/	F0	 F100
. (4)
Ultimately, we wished to determine R, the fraction of membrane-bound N-
(or C-) terminus biotinylated GALA that exposed its N- (or C-) terminus on
the outside of the POPC liposome at pH 5.0 during the external layer
exposure measurement and bound via its biotin moiety to BODIPY-avidin
added to the liposome/peptide solution. To determine R, we needed to
determine Z, the fraction of biotinylated peptides released on the outside of
the liposomes after the pH elevation to 8.0 in the control pH-dissociation
exposure.
To determine Z, we performed two additional controls similar to the
pH-dissociation exposure and no exposure mentioned above, except that
the detergent dodecyloctaethylene glycol monoether (C12E8) was added at
the end of both protocols, to lyse the vesicles. The final fluorescence
intensities were FZ100 and FZ0, respectively.
In a third measurement, denoted control “total exposure,” the procedure
was identical to that of the control pH-dissociation exposure, except that
the addition of C12E8 preceded that of d-biotin. This treatment generated
the complete release of the biotinylated peptides in solution before the
addition of d-biotin. Thus, all the biotinylated peptides bound to BODIPY-
avidin. When d-biotin was added, it saturated the remaining BODIPY-
avidin binding sites not occupied by the biotinylated GALA. The fluores-
cence intensity at the end of the control total exposure was FZ100. The
fraction of biotinylated peptides released on the outside of the POPC
vesicles after the pH elevation to 8.0 in the control pH-dissociation expo-
sure, Z, could be determined by
Z 	FZ0	 FZ100
/	FZ0	 FZ100
. (5)
Because r  R/Z by definition, R could be determined directly from r and
Z, using
R r  Z. (6)
When the C-terminus-labeled GALAs (GALA(C)s) were studied, the
difference (FZ0  FZ100) at pH 8.0 was too small. To accurately determine
Z in this case, the pH was decreased to 5.0 at the end of the three
measurements. This increased the difference between FZ100 and FZ0 and
consequently enhanced the accuracy of the determination of Z.
Determination of internal accessibility of
biotinylated peptide by pre-encapsulation of
BODIPY-avidin
In this assay, BODIPY-avidin was pre-encapsulated in POPC liposomes.
The assay required the measurement of three fluorescence intensities at the
wavelength corresponding to maximum emission of BODIPY (  510
nm). From these intensities, we could determine R, the fraction of lipo-
some-bound N- (or C-) terminus biotinylated GALA that bound at pH 5.0
to pre-encapsulated BODIPY-avidin. R corresponded to the fraction of
bilayer-bound peptides exposing their N- (or C-) termini on the internal
side of the vesicles.
The procedure with the N-terminus biotinylated peptides GALA(N),
(GALA(N)1, and GALA(N)2) was as follows. To begin the measurement
leading to the first fluorescence intensity, denoted “internal layer expo-
sure,” an aliquot of a mixture of GALA 30 and GALA(N) (at a molar ratio
of 14/1) in a 3 mM TES, 50 mM KCl (pH 8.0) buffer was added to the
stirred 2.5 mL suspension of vesicles containing BODIPY-avidin (0.65
mM POPC) at 20°C, in a 25 mM TES, 80 mM KCl (pH 5.0) buffer. A
lipid/total membrane-bound peptide molar ratio of 2500/1 was used, which
corresponded to a BODIPY-avidin binding site/biotinylated GALA molar
ratio of 8/1. At the lipid concentration used (0.65 mM), 80% of the peptide
bound to the vesicles (Nicol et al., 1996). Every membrane-bound biotin-
ylated GALA that exposed its biotinylated terminus on the internal side of
the vesicle bound to a BODIPY-avidin. After 15 min, d-biotin was added
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to the solution at a d-biotin/BODIPY-avidin molar ratio of 64/1. A conse-
quence of the formation of pores by GALA in POPC vesicles at pH 5.0 is
that d-biotin (244.3 MW) could easily translocate into the liposome and
saturate the BODIPY-avidin binding sites not occupied by the biotinylated
GALA. The pH of the solution was then elevated to 8.0 by adding 200 L
of a 0.5 M TES pH  8.5 solution, and the vesicles were lysed with the
detergent C12E8. The final fluorescence intensity, F, was recorded 3 min
after lysing the vesicles.
For the fluorescence measurement required to obtain the second inten-
sity, denoted control total exposure, the step of addition of the peptide
mixture to the liposome suspension was identical to the first fluorescence
measurement. Fifteen minutes after the peptide addition, the pH of the
solution was elevated to 8.0 by adding 200 L of a 0.5 M TES, pH  8.5
solution, and the vesicles were lysed. At this point, each biotinylated
GALA bound to a BODIPY-avidin binding site. After 3 min, d-biotin
was added to the solution at a d-biotin/BODIPY-avidin molar ratio of 64/1.
Again, d-biotin bound to the BODIPY-avidin binding sites that were not
occupied by the biotinylated GALA. The final fluorescence intensity, F100,
was recorded 3 min after the addition of d-biotin.
For the third fluorescence measurement required for the computation of
R, denoted control no exposure, the protocol was identical to that used to
obtain the first intensity, except that the peptide mixture consisted exclu-
sively of nonbiotinylated GALA 30 at the same total peptide concentration.
The final fluorescence intensity, F0, was recorded 3 min after the pH
elevation.
Let R be the fraction of N-terminus biotinylated GALA(N) that ex-
posed its N-terminus on the internal side of the POPC liposomes in the
internal layer exposure experiment at pH 5.0 and bound, via its biotin tag,
to pre-encapsulated BODIPY-avidin. As in the determination of r, i.e.,
addition of BODIPY-avidin on the outside of the liposomes, R could be
determined by using an equation similar to Eq. 4,
R 	F0	 F
/	F0	 F100
. (7)
The refinement used to determine R from r was not needed in this assay,
because the addition of C12E8 and the pH elevation released all the peptides
in solution in the control total exposure before addition of d-biotin. Let R
be the fraction of membrane-bound GALA(N) that displayed its N-termi-
nus on the internal side of the liposomes. R could be determined from R,
because the fraction of membrane-bound peptide, Y ( 0.8), is known
(Nicol et al., 1996):
R R/Y. (8)
When the C-terminus labeled GALA(C)3 was studied, the pH was not
elevated to 8.0 in the three experiments, because (F0 F100) was too small
to accurately determine R. Instead, the pH was kept at 5.0 where (F0 
F100) was higher. However, the equations to determine R and R were
identical to those used for the N-terminus biotinylated peptides GALA(N).
Simultaneous determination of internal and
external accessibility of biotinylated peptide by
pre-encapsulation and external addition of
BODIPY-avidin
In this assay, we determined the fraction of biotinylated peptide that bound
at pH 5.0 to BODIPY-avidin present on both sides of the POPC bilayer.
The protocol described above to determine R was modified by the addition
of BODIPY-avidin in solution in the three measurements, 15 min after the
addition of the peptide mixture, at a BODIPY-avidin binding site/biotin-
ylated GALA molar ratio of 6/1. Fifteen minutes later, d-biotin was added
to the solution in the control no exposure and the “internal external sides
exposure” measurement (that replaces the internal exposure measurement),
and the pH was elevated to 8.0 for the control total exposure. The rest of
the three measurements were identical to that mentioned above for the
determination of R. The three final fluorescence intensities were denoted
F0, F, and F100, in a similar fashion to that used for the determination of
R. Using Eq. 7, we could determine Rtotal (instead of R), the fraction of
biotinylated GALA that bound to BODIPY-avidin at pH 5.0 either on the
internal or on the external side of the vesicles during the internal external
sides exposure experiment. The fraction of labeled peptide whose biotin
moiety was inaccessible to BODIPY-avidin binding, in the time-frame of
the experiment, was given by (1 Rtotal).
Theoretical analysis of the formation of
transmembrane aggregates and pores
Our model of bilayer permeabilization by GALA assumes that 1) in the
presence of liposomes the peptides bind and become incorporated into the
bilayer of the vesicles, and 2) peptide aggregation occurs within the
membrane. When an aggregate has reached a critical size within a bilayer,
i.e., it consists of M peptides, a pore is created and complete leakage of
liposome-encapsulated molecules occurs. The size of the pore depends on
the number of peptides forming it and dictates the upper bound on the size
and shape of molecules that can leak.
Here, we present a few selected equations derived from the model. A
more complete description can be found in Rapaport et al. (1996) and in
Nicol et al. (1996).
Adapting for surface aggregation of the membrane-bound GALA, the
general scheme, as treated in Bentz and Nir (1981) and Nir et al. (1983),
gives
X1 X1 ¢O¡
C11
D11
X2 Xi Xj ¢O¡
Cij
Dij
Xij (9)
where Xi are molar (or surface) concentrations of aggregates of order i. We
have used the same simplifications made by Smoluchowski (1917) and by
Blatz and Tobolsky (1945), i.e., that Cij  C and Dij  D for all i and j.
The fraction of liposome-encapsulated molecules that has leaked at the
plateau level is denoted by L. Because of the dependence of the encapsu-
lated volume on the third power of the inner diameter, a small fraction of
large vesicles can contribute significantly to L. As in Fattal et al. (1994), we
considered the vesicles to consist of j  1, 2, . . . , S size classes. The
distribution of vesicles according to their diameters was determined by
dynamic light scattering. We set S  10 and we denote the fraction of
encapsulated volume in vesicles of type j by fj, 1 
 j 
 10. Let Aij be the
normalized fraction of vesicles of size class j that contain i bound peptides,
i.e.,

i0
Nj
Aij 1, (10)
in which Nj is the largest number of peptides that can bind to a vesicle of
size class j. The procedure for calculating the quantities Aij from the
peptide and lipid concentrations and the fraction of peptides that is bound
to the vesicles at these concentrations was as in Nir et al., 1994. In the
general case of reversible aggregation of the peptide, the expression for L
is
L 
j1
s 
iM
Nj
Z	M, i, j, Ks
Ai , j fj, (11)
in which Z(M, i, j, Ks) is the probability that a vesicle of size class j that
contains i bound peptides will include an aggregate consisting of M or
more peptides (only aggregates that induce leakage of encapsulated mol-
ecules), and Ks measures the reversibility of peptide aggregation in the
membrane and is given by
Ks C/D (12)
in which C and D are the rate constants of peptide association and
dissociation, respectively.
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In previous studies, we have used this model to analyze the evolution of
percent ANTS/DPX leakage from POPC or egg PC liposomes at pH 5.0 as
a function of lipid/membrane-bound peptide molar ratio. We demonstrated
that only GALA aggregates composed of i peptides, with i  M  10 
2 peptides, act as pores that induce the leakage of pre-encapsulated ANTS/
DPX (Parente et al., 1990a; Nicol et al., 1996). As pointed out in Nicol et
al. (1996), in these cases, Z approaches unity and Ks is large, reflecting the
quasi-irreversibility of GALA aggregation in POPC and egg PC mem-
branes. This reduces Eq. 11 to that derived in Parente et al. (1990a).
In the current work, we also performed calculations for a situation in
which GALA aggregates formed on the membrane surface become trans-
membrane when they reach a critical size of M peptides, a size at which
ANTS/DPX cannot leak (M  10  2). The model permits calculation of
the fraction of membrane-bound peptides that would be involved in trans-
membrane aggregates. Indeed, in analogy to Eq. 11, the fraction P of
peptides participating in aggregates of size i, with i  M, can be calculated
using
P 
j1
s 
iM
Nj
Z	M, i, j, Ks
Ai, jQj, (13)
in which Qj is the fraction of total surface area in vesicles of type j. The
model assumes that, in a vesicle where an aggregate of size i, with i  M,
is formed (this situation occurs in almost all vesicles that contain M or
more bound peptides because Z is close to 1), each peptide bound to this
vesicle is involved in such an aggregate. We believe that this assumption
results in a negligible overestimation of the peptide fraction involved in an
aggregate of size i, with i  M, when M  4 or 6.
RESULTS AND DISCUSSION
ANTS/DPX leakage induced by the
GALA peptides
We compared the potency of the GALA peptides to induce
ANTS/DPX leakage from neutral POPC LUV at pH 5.0.
The efficiency with which the unlabeled peptides GALA
29CC, GALA 31CC, and GALA 31CN induced leakage was
almost identical to that of GALA 30 (Fig. 2 A). Thus, their
ability to form pores in the POPC bilayer was unaltered by
the slight modification made from the original GALA 30
sequence (Subbarao et al., 1987; Parente et al., 1990a,b;
Nicol et al., 1996). In addition, biotinylation of the GALA
peptides modified their leakage activity only slightly; this
was dependent on the labeling reagent and the biotinylation
site on the peptide (Fig. 2 B).
Biotinylation of GALA 30 on the primary amine of the
N-terminus yielded a peptide (GALA(N)1) with a slightly
increased ability to induce ANTS/DPX leakage. Indeed,
higher leakage extents were obtained with GALA(N)1 for
the same lipid-to-peptide molar ratios. This difference
might arise from the higher hydrophobicity of GALA(N)1,
because of the removal of the positive charge at the bioti-
nylation site. Extension of GALA 30 by addition of a
cysteine at the N-terminus (GALA 31CN) and subsequent
biotinylation at the free thiol group of this cysteine yielded
a peptide, GALA(N)2, with a similar efficiency to perme-
abilize POPC vesicles as the starting sequence. The com-
parable activity of GALA 30 and its two biotinylated ana-
logs GALA(N)1 and GALA(N)2 implies that the peptides
labeled at the N-terminus were suitable for studying GALA
30 surface-adsorbed or transbilayer orientation as well as
the head-to-tail (N- to C-terminus) orientation of the trans-
bilayer peptides in POPC liposomes.
Regarding the C-terminus labeling, biotinylation of
GALA 29CC at the cysteine (second amino acid from the
C-terminus) yielded a peptide, GALA(C)2, with a reduced
FIGURE 2 Final extent of ANTS/DPX leakage from POPC liposomes as
a function of lipid/peptide molar ratio at pH 5.0. (A) Leakage induced by
the nonbiotinylated GALAs (GALA 30 (E), GALA 29CC (), GALA
31CC (‚) and GALA 31CN ()). (B) Leakage induced by GALA 30 (E)
and the biotinylated GALAs (GALA(N)1 (), GALA(N)2 (‚), GA-
LA(C)2 () and GALA(C)3 (ƒ). The lipid concentration remained con-
stant at 0.1 mM. Each data point is an average of three experiments. For
every peptide tested, the final extent of leakage at a given lipid/peptide
molar ratio varied no more than4%
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activity in comparison to that of GALA 29CC (Fig. 2 B). At
the same lipid concentration used (0.1 mM), a two-fold
increase in GALA(C)2 concentrations above those of
GALA 29CC was required to obtain the same extent of
ANTS/DPX leakage. An improvement in the efficiency of a
C-terminus-labeled GALA was achieved with the biotiny-
lation of GALA 31CC, that led to the peptide GALA(C)3. In
this case, only 30 mol% more biotinylated peptide than
GALA 31CC was needed to obtain the same extent of
leakage (Fig. 2 B).
In GALA 31CC, the cysteine is located on the hydrophilic
side of the membrane-bound amphipathic helix. Con-
versely, the cysteine of GALA 29CC is positioned on the
hydrophobic side of the helix. Biotinylation on the apolar
side may interfere with peptide–peptide and lipid–peptide
hydrophobic interactions involved in the formation of the
GALA pore. This effect would explain the lower efficiency
of GALA(C)2 in comparison to that of GALA(C)3. The
similar activity of GALA(C)3, its nonbiotinylated version
GALA 31CC, and GALA 30 made GALA(C)3 a suitable
C-terminus-labeled peptide for studying GALA 30 surface-
adsorbed or transbilayer orientation as well as the head-to-
tail (N- to C-terminus) orientation of the transbilayer pep-
tides in POPC liposomes. Overall, the similar leakage
efficiency of GALA 30 and the biotinylated peptides em-
phasizes that the size of the label is not big enough to
interfere with pore formation and dye leakage through the
pore.
In the following experiments, we used a mixture of
GALA 30 and a biotinylated GALA at molar ratios of 19/1,
9/1, 85/15, or 3/1 to determine GALA orientation in POPC
bilayers. These mixtures exhibited the same efficiency to
induce ANTS/DPX leakage as GALA 30.
Enhanced fluorescence of BODIPY-avidin upon
its binding to d-biotin or to a biotinylated GALA
peptide at pH 8.0
It has been observed that the binding of a biotin moiety to
a BODIPY-modified avidin enhances the fluorescence of
the BODIPY chromophore (Emans et al., 1995). We have
monitored the enhancement of BODIPY fluorescence at its
emission maximum (  510 nm) resulting from the bind-
ing of d-biotin or a biotinylated GALA peptide to BODIPY-
avidin. Avidin is a tetramer in which each monomer consists
of an eight-stranded antiparallel -barrel (Pugliese et al.,
1993). The biotin binding site is located in a deep pocket
near the center of the barrel in which two of the four
tryptophan residues reside. It has been suggested that a
static interaction between tryptophan and BODIPY chro-
mophores results in quenching of their fluorescence. Biotin
binding to BODIPY-avidin yields a conformational change
of the protein that may weaken the interaction and conse-
quently dequenches both BODIPY and tryptophan fluores-
cence (Emans et al., 1995).
In Fig. 3, the fluorescence intensity of the BODIPY-
avidin/biotin complex in solution at pH 8.0 (Ex  480 nm,
Em  510 nm) is displayed as a function of the biotin
moiety-to-BODIPY-avidin molar ratio, for a constant con-
centration of BODIPY-avidin (0.1 M). In comparison to
the fluorescence intensity obtained without biotin binding
(intensity of 1 in arbitrary units), a maximum enhancement
of 4.6 was obtained when d-biotin was added to saturation of
the four binding sites of the BODIPY-avidin molecules. C-
terminus biotinylated peptides were slightly less efficient in
dequenching BODIPY fluorescence; at saturation of the
BODIPY-avidin binding sites, the intensity was 3.6 and
3.2 when using GALA(C)2 and GALA(C)3, respectively. The
lowest fluorescence enhancement (2.3) was obtained with the
N-terminus-labeled peptides GALA(N)1 and GALA(N)2.
In comparison to d-biotin, we suggest that the reduced
enhancement of BODIPY-avidin fluorescence observed
with GALA(C)s, and to a greater extent with GALA(N)s, is
due to the presence of a tryptophan at the N-terminus of
GALA. The dequenching of BODIPY-avidin fluorescence
resulting from its binding to a biotin moiety is partially
offset by a quenching effect caused by the peptide’s tryp-
tophan. This explanation is consistent with the observed
sensitivity of BODIPY fluorescence to the aromatic amino
acids tyrosine and tryptophan (Karolin et al., 1994). The
tryptophan-induced quenching of BODIPY-avidin fluores-
cence depends on the average distance between the biotin
moiety of the peptide and its tryptophan, because it was
more pronounced with GALA(N)s than with GALA(C)s.
For each biotinylated peptide as well as for d-biotin, the
plateau of fluorescence enhancement was obtained at a
FIGURE 3 Differential enhancement of BODIPY-avidin fluorescence
upon its binding to d-biotin or to a biotinylated GALA peptide at pH 8.0
as a function of biotin/avidin molar ratio. Biotinylated molecules used were
d-biotin (E), GALA(N)1 (), GALA(N)2 (‚), GALA(C)2 () and
GALA(C)3 (ƒ). We monitored the fluorescence of BODIPY-avidin at 
510 nm (2.5 mm slits), when the samples were irradiated at   480 nm
(1.25 mm slits). Duplicate experiments resulted in values that differed by
up to 5%.
2128 Biophysical Journal Volume 76 April 1999
biotin moiety-to-BODIPY-avidin molar ratio of 4, which
corresponds to the number of binding sites per BODIPY-
avidin molecule. Under the conditions tested, the enhance-
ment of BODIPY-avidin fluorescence was not altered by the
presence of POPC liposomes in the solution at pH 8.0 (data
not shown).
In the time-frame of our experiments (less than 1 h), the
binding of a biotinylated GALA or d-biotin to BODIPY-
avidin at pH 8.0 was irreversible (data not shown). Indeed,
when BODIPY-avidin binding sites were presaturated with
GALA(N)1 or GALA(C)3 (using a biotinylated-GALA-to-
BODIPY-avidin binding site molar ratio of 2), the fluores-
cence of the complex was not altered by the addition of a
4/1 excess of d-biotin over the BODIPY-avidin binding
sites. Furthermore, when the BODIPY-avidin binding sites
were presaturated with d-biotin and a biotinylated GALA
was added in excess, no decrease of BODIPY-avidin fluo-
rescence was observed.
Determination of GALA head-to-tail (N- to C-
terminus) orientation in POPC bilayers at pH 5.0
by the external addition of BODIPY-avidin
To determine the fraction of membrane-bound biotinylated
GALA that exposes its labeled terminus on the external side
of the POPC vesicles at pH 5.0, we used the differential
enhancement of BODIPY-avidin fluorescence upon its ir-
reversible binding to d-biotin or to a biotinylated GALA.
The assay was based on the following elements: 1) The lipid
concentration was such (2.5 mM) that all added GALA
bound to the liposomes at pH 5.0 (Nicol et al., 1996), but
none remained bound when the pH was elevated to 8.0.
(Parente et al., 1990b). 2) BODIPY-avidin (60,000 MW)
added to the peptides/vesicle solution did not permeate
through the liposome membrane. 3) A biotinylated GALA
or a d-biotin bound to BODIPY-avidin could not be ex-
changed by a d-biotin, or a biotinylated GALA, respec-
tively. We believe that the quasi-irreversibility of biotin/
BODIPY-avidin binding demonstrated at pH 8.0 in the
presence or absence of liposomes can be extended to pH
5.0.
The assay, described in detail in Materials and Methods
and illustrated in Fig. 1, comprised three independent fluo-
rescence measurements. Each measurement yielded a fluo-
rescence intensity required to determine the external expo-
sure of GALA’s labeled terminus. During each
measurement, the sample was irradiated at  480 nm, and
the light emitted was monitored at  510 nm (wavelength
where BODIPY-avidin fluorescence emission was maxi-
mal). Measurements carried out with the biotinylated pep-
tides GALA(N)1, GALA(C)2, and GALA(C)3 yielded
traces like those displayed in Fig. 4 A, B, and C, respec-
tively. In these measurements, a lipid/total peptide molar
ratio of 2500/1, a lipid concentration of 2.5 mM, and a
BODIPY-avidin binding site/biotinylated GALA molar ra-
tio of 8 were used. Measurements performed with GA-
LA(N)2 resulted in similar traces as those obtained with
GALA(N)1.
Typical traces obtained from the three measurements
with GALA(N)1 are presented in Fig. 4 A. In the control no
exposure (trace 1), the addition of BODIPY-avidin to the
nonbiotinylated GALA 30/POPC liposome solution at pH
5.0 generated an increase in fluorescence, as expected.
When d-biotin was added to the solution 15 min later, the
saturation of the BODIPY-avidin binding sites by d-biotin
produced an appreciable dequenching of BODIPY-avidin
fluorescence. The subsequent pH elevation to 8.0 led to a
small increase of the fluorescence intensity. At the end of
the control no exposure, the BODIPY-avidin binding sites
were all occupied by a d-biotin. A modification in the order
of the addition steps did not affect the final fluorescence
intensity F0 (data not shown).
The addition of BODIPY-avidin to the [GALA 30/GA-
LA(N)1]/POPC liposome solution in the external layer ex-
posure measurement and in the control pH-dissociation
exposure (traces 2 and 3, respectively) led to a fluorescence
intensity that reached a plateau after a few minutes to a level
slightly higher than that observed in the control no expo-
sure. This level was higher because of BODIPY-avidin
binding to the GALA(N)1 peptides that exposed their N-
termini on the external side of the liposomes.
The external layer exposure measurement required the
addition of an excess of d-biotin (trace 2). D-biotin bound
to the unoccupied BODIPY-avidin binding sites. The fluo-
rescence increase that followed this addition was lower than
that observed for the control no exposure (trace 1), because
of the partial binding of the biotinylated peptides to
BODIPY-avidin. Indeed, the binding of a N-terminus bio-
tinylated GALA to BODIPY-avidin dequenches BODIPY
fluorescence less than the binding of a d-biotin. The subse-
quent pH elevation to 8.0 released all the peptides from the
POPC bilayer, including the biotinylated ones that were
exposed on the outside of the liposomes and that bound to
a BODIPY-avidin molecule. (Z  100)% of the biotinylated
peptides were released on the outside of the vesicles (in-
cluding those bound to BODIPY-avidin), and a small frac-
tion of peptide was released on the inside of the liposomes
(see Materials and Methods). This pH elevation induced a
further dequenching of BODIPY-avidin fluorescence, as
observed in the control no exposure.
At the end of the external layer exposure protocol, only
the fraction of membrane-bound GALA(N)1 that exposed
its biotin moiety on the external side of the POPC liposomes
at pH 5.0 was bound to a BODIPY-avidin molecule. Pep-
tides that displayed their biotin tags on the internal side of
the liposomes did not bind to BODIPY-avidin. BODIPY-
avidin binding sites that were not occupied by a labeled
GALA were associated with a d-biotin. The partial binding
of GALA(N)1 to BODIPY-avidin explains the reduced final
fluorescence intensity F (trace 2) in comparison to that of
the control no exposure, F0 (trace 1).
After the addition of BODIPY-avidin in the control pH-
dissociation exposure (trace 3), the pH was increased to 8.0,
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and then d-biotin was added. As mentioned above, the pH
elevation released all the GALA peptides from the mem-
branes, Z  100% of the biotinylated peptides being released
on the outside of the vesicles. Thus, Z  100% of the
biotinylated GALA molecules bound to BODIPY-avidin.
This additional binding was partially responsible for the
increase in BODIPY-avidin fluorescence subsequent to in-
creasing the pH. When d-biotin was added to the solution
3 min later, the binding of d-biotin to the remaining
BODIPY-avidin binding sites induced a further dequench-
ing of BODIPY-avidin fluorescence. At the end of the
control pH-dissociation exposure, every biotinylated GALA
released on the outside of the vesicles was bound to a
BODIPY-avidin molecule. The sites not occupied by a
labeled GALA were associated with a d-biotin. The almost
complete binding of GALA(N)1 (Z  100% of the peptides)
to BODIPY-avidin explains why the final fluorescence of
the control pH-dissociation exposure, F100, (trace 3) was
lower than that of the external layer exposure experiment, F,
(trace 2).
From the three fluorescence intensities F, F100, and F0,
and the separately determined Z (see Materials and Meth-
ods), the fraction of membrane-bound GALA(N)1 that ex-
posed its N-terminus on the external side of the POPC
vesicles at pH 5.0, R, could be calculated (Eqs. 1–6).
Molar ratios of BODIPY-avidin binding sites to biotin-
ylated GALA of 8 and above were used in this assay to
ensure that, at most, one biotinylated GALA bound to a
BODIPY-avidin. We found a similar R value when this ratio
was varied from 8 to 20 (data not shown), which implies
that a ratio of 8 was sufficient to meet this criterion.
At pH 5.0 and a lipid/peptide molar ratio of 2500/1,
GALA 30 forms pores of 8 to 13 peptides in POPC vesicles
(Subbarao et al., 1987; Parente et al., 1990a; Nicol et al.,
1996). If two biotinylated GALAs participate in the same
pore, we anticipate a steric hindrance for the binding of two
BODIPY-avidin molecules to these two biotin moieties.
This situation could prevent BODIPY-avidin binding of one
of these biotin tags. We used a molar ratio of unlabeled
GALA 30 to biotinylated GALA of 19/1 to minimize this
possibility. This ratio also significantly reduced the chances
of binding of one BODIPY-avidin molecule to two mem-
brane-bound biotinylated GALAs.
There were remarkable differences between traces ob-
tained with the GALA(N) peptides (Fig. 4 A) and that
acquired with the GALA(C) analogs (Fig. 4 B and C). In the
external layer exposure (trace 2) and the control pH-disso-
ciation exposure (trace 3), the fluorescence increase follow-
ing BODIPY-avidin addition was higher with the GALA(C)
peptides than with the GALA(N) peptides. This difference
was the result of two factors: first, GALA predominantly
exposed its C-terminus to the external side of the vesicles.
Second, the tryptophan of a GALA(C) bound to BODIPY-
avidin was a less effective quencher of BODIPY-avidin
fluorescence than the tryptophan of a bound GALA(N).
This is due to a variation in the distance between the biotin
moiety of the peptide and its tryptophan. This structural
difference also explains why the differential intensity (F0 
F100) was lower when GALA(C) peptides were used.
The assay is sensitive to a number of factors, and we
found it necessary to use an excess of BODIPY-avidin over
the biotinylated GALA (in traces 2 (T2) and 3 (T3) of Fig.
4 A–C) and to perform a pH elevation in the three measure-
ments (in traces 1 (T1), 2 and 3). This results in two
populations of BODIPY-avidin molecules at the end of the
measurements, one in solution at pH 8.0 completely filled
with d-biotin, the other also in solution at pH 8.0 being
filled 3⁄4 with d-biotin and 1⁄4 with a biotinylated GALA (this
population does not exist in T1 because we do not use
biotinylated GALA). At the end of the measurements, the
only difference between them is in the proportions of the
two populations of BODIPY-avidin, which makes the de-
termination of R possible. Before the measurements are
finished, we cannot quantitate R, because the BODIPY-
avidin molecules are in different states in the three mea-
surements. These differences in the state of BODIPY-avidin
molecules explain, for example, the difference in fluores-
cence increase following pH elevation among T1, T2, and
T3. This can be illustrated with the help of Fig. 5.
In T1 (Fig. 5), all the BODIPY-avidin molecules are free
in solution, with their binding sites filled with d-biotin,
before and after the pH increase to 8.0. In that case, the
increase in BODIPY fluorescence following pH elevation
arises only from the influence of pH on the fluorescence
intensity of BODIPY-avidin molecules filled with d-biotin.
The effect of pH elevation is similar in T2 for the fraction
(1  A) of BODIPY-avidin molecules filled with d-biotin.
However, for the BODIPY-avidin molecules (fraction A)
that contain a biotinylated GALA (3 of their sites are filled
with d-biotin and one with biotinylated GALA), the pH
FIGURE 4 Determination of R, the fraction of biotinylated GALA that exposes its labeled terminus to the external side of POPC liposomes at pH 5.0.
T1, T2, and T3 are traces that refer to the control no exposure (T1), the external layer exposure measurement (T2), and the control pH-dissociation exposure
(T3). Traces were obtained by monitoring the light emitted at   510 nm and following the protocol described in Materials and Methods. r  R/Z was
calculated from the fluorescence intensities F0, F, and F100 obtained at the end of the three independent measurements, by using Eq. 4. From r and a
separate determination of Z (see Materials and Methods), R could be calculated. At t 0, T2 and T3 refer to solutions at pH 5.0 that contain POPC vesicles
(2.5 mM lipid) and a mixture of GALA 30/biotinylated GALA 19/1 (1 M total peptide). The peptide mixture was replaced by 1 M nonbiotinylated
GALA 30 in T1. Arrows indicate additions performed during the three measurements. A lipid/total peptide molar ratio of 2500/1 and a d-biotin/BODIPY-
avidin binding site molar ratio of 4/1 were used in these measurements. In T2 and T3, a BODIPY-avidin binding site/biotinylated GALA molar ratio of
8/1 was used. The biotinylated GALAs tested are (A) GALA(N)1, (B) GALA(C)2, and (C) GALA(C)3 F0, F, F100, and r ( R/Z) values of these particular
sets of measurements are listed in Table 1.
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increase induces a change in their environment, as illus-
trated in T2 of Fig. 5. These BODIPY-avidin molecules
evolve from a state in which they are close to the liposome
membrane at pH 5.0 (the biotinylated GALA that is bound
to them is inserted in the membrane) to a situation in which
they are free in solution at pH 8.0, and the biotinylated
GALA that is bound to them is an anionic random coil. This
modification of the environment influences the change in
fluorescence following pH elevation.
In T3, the pH increase induces the same environmental
modifications for a similar fraction of the BODIPY-avidin
molecules (fraction A), except that the 3 binding sites that
are not occupied by a biotinylated GALA are free instead of
being filled with d-biotin. Figure 5 illustrates that, in addi-
tion to this fraction of BODIPY-avidin molecules, there is
another fraction (B) that remains in solution and binds to a
biotinylated GALA following the pH increase. The fluores-
cence intensity of these latter BODIPY-avidin molecules
should increase not only because of the pH increase per se
{as in trace 1 or with fraction (1  A) of T2 and fraction
[1  (A  B)] of T3}, but also because of the binding of a
biotinylated GALA.
If the fraction A of BODIPY-avidin was undergoing the
same fluorescence increase in T2 and in T3 following the
pH elevation, then the total fluorescence increase in T3
should be higher than that in T2, because of the additional
binding of a biotinylated GALA to fraction B in T3. How-
ever, we believe that fraction A in T2 undergoes a fluores-
cence increase much higher than fraction A in trace 3. In T2
and T3, if the fluorescence increase of fraction A after the
pH elevation involves only the BODIPY fluorophore cou-
pled to the binding site occupied by the biotinylated GALA,
this increase should be the same for both traces. However,
we believe that the BODIPY fluorophore coupled to each of
the 3 avidin binding sites occupied by a d-biotin (fraction A
in T2) undergoes a higher fluorescence increase due to pH
elevation than the the BODIPY fluorophore coupled to each
of the 3 unoccupied binding sites (fraction A in T3). This
effect would explain why the total fluorescence increase in
trace 2 is higher than that in trace 3. The reason for the
higher increase in fluorescence of fraction A in trace 2 than
in trace 3 could arise from a quenching of BODIPY fluo-
rescence before pH elevation, this quenching being higher
for binding sites filled with d-biotin than for unoccupied
binding sites. The quenching could arise from the proximity
of the BODIPY-avidin molecule to the membrane surface or
from its proximity to GALA peptides that are forming a
membrane aggregate with the biotinylated GALA bound to
the BODIPY-avidin molecule. A similar kind of explana-
tion can be put forward for the difference in fluorescence
FIGURE 5 Illustration of the effect
of pH on BODIPY-avidin in traces 1,
2, and 3 of Fig. 4
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increase between T2 and T3 following detergent addition in
Fig. 6.
The fluorescence intensities F0, F, and F100, and the
intermediate parameter r determined from the measure-
ments displayed in Fig. 4, are listed in Table 1, as well as the
R value determined from 3 to 6 sets of measurements of r
and Z.
Measurements carried out with the N-terminus biotinyl-
ated peptides GALA(N)1 and GALA(N)2 yielded RN values
(R values related to N-terminus biotinylated GALAs) of
0.265 and 0.255, respectively. These RN values correspond
to the fraction of membrane-bound GALA(N) that exposed
its N-terminus on the external side of the POPC liposomes
at pH 5.0. The corresponding Z values were 0.87 and 0.86,
FIGURE 6 Determination of R, the fraction of biotinylated GALA that exposes its labeled terminus to the internal side of POPC liposomes at pH 5.0.
T1, T2, and T3 are traces that refer to the control no exposure (T1), the internal layer exposure determination (T2), and the control total exposure (T3).
Traces were obtained by monitoring the light emitted at  510 nm and following the protocol described in Materials and Methods. R could be calculated
from the fluorescence intensities F0, F, and F100 obtained at the end of the three independent measurements, by using Eq. 7 and R  R/0.8. At t  0,
T1, T2, and T3 refer to solutions at pH 5.0 that contain POPC vesicles (0.65 mM lipid) with pre-encapsulated BODIPY-avidin. Arrows indicate additions
performed during the measurements. A lipid/total membrane-bound peptide molar ratio of 2500/1 and a d-biotin/BODIPY-avidin binding site molar ratio
of 16/1 were used in these measurements. In T2 and T3, a BODIPY-avidin binding site/biotinylated GALA molar ratio of 8/1 and a GALA 30/biotinylated
GALA molar ratio of 14/1 were used. The biotinylated GALAs tested were (A) GALA(N)1 and (B) GALA(C)3. F0, F, F100, R, and R values of these
particular sets of measurements are listed in Table 1.
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respectively, meaning that most of the biotinylated peptides
were released on the outside of the vesicles after the pH
elevation during the control pH-dissociation exposure.
Experiments performed with the C-terminus biotinylated
peptides GALA(C)2 and GALA(C)3 yielded RC values (R
values related to C-terminus biotinylated GALAs) of 0.81
and 0.73, respectively (Table 1). The corresponding Z val-
ues were 0.97 and 0.95, respectively.
The biotinylated peptides (particularly GALA(N)1, GA-
LA(N)2, and GALA(C)3) exhibited a similar efficiency to
induce ANTS/DPX leakage as the unlabeled peptide GALA
30 (Fig. 2 B), which demonstrates that the biotin-modified
peptides have pore-forming properties comparable to
GALA 30. Thus, we believe that the orientation of GALA
30 in the bilayer [surface-adsorbed or transmembrane ori-
entation as well as the head-to-tail (N- to C-terminus) ori-
entation of the transbilayer peptide] and that of the biotin-
ylated peptides are similar. Therefore, the RN and RC values
determined with the biotinylated peptides characterize the
exposure of GALA 30 termini and the orientation of the
unlabeled peptide in the bilayer. We cannot rule out the
possibility that biotinylation influences peptide orientation
to some extent. However, GALA(N)1 and GALA(N)2 are
labeled on different sites on the N-terminus with a different
biotinylation reagent but yield similar RN values. In addi-
tion, GALA(N)1 and GALA(C)3 are labeled with the same
biotinylation reagent, both on a cysteine on the hydrophilic
side of the helix, but the R value associated with GALA(N)1
N-terminus (RN) and the R value associated with GA-
LA(C)3 C-terminus (RC) are significantly different and
complementary (RN  RC  1, see next paragraph). These
results emphasize that GALA orientation is not significantly
affected by biotinylation.
We attribute more significance to the results obtained
with GALA(C)3 than that generated with GALA(C)2, be-
cause the efficiency of GALA(C)3 to induce ANTS/DPX
leakage was closer to that of GALA 30. Therefore, we
expect GALA(C)3 to better mimic GALA 30 behavior. The
importance of selecting the right biotinylation reagent can
be illustrated by our first attempt to label GALA 29CC at the
C-terminus with N-(3-maleimidylpropionyl) biocytin. This
labeling resulted in a peptide (GALA(C)1) with a highly
reduced efficiency to induce ANTS/DPX leakage in com-
parison to that of GALA 29CC. Determination of the orien-
tation of this peptide at a lipid/peptide ratio of 2500/1
yielded an external exposure of its labeled C-terminus close
to 100% (data not shown). This almost complete external
exposure was most probably arising from a reduced inser-
tion of the peptide in the membrane, leading to reduced pore
formation and ANTS/DPX leakage. We believe this effect
of the labeling reagent was caused by its negatively charged
carboxylic acid that prevented peptide aggregation in the
membrane and/or aggregate insertion.
The sum of the R value obtained with GALA(C)3 (RC 
0.73) and that obtained with the GALA(N) peptides (RN 
0.265 or 0.255) is close to 1, which supports the notion that,
at a lipid/peptide molar ratio of 2500/1, only one terminus
per membrane-bound GALA (GALA(N), GALA(C)3, or
GALA 30) is exposed to the external side of the POPC
bilayer. This result implies that a vast majority of the GALA
peptides are involved in transmembrane aggregates, as op-
posed to being adsorbed on the membrane surface. Fourier
transform infrared spectroscopy studies previously indi-
cated that the orientation of membrane-bound GALA 30 is
parallel to the POPC bilayer normal, at pH 5.0, and at low
lipid/peptide molar ratios (Goormaghtigh et al., 1991).
From the present experiments, we can conclude that the
head-to-tail (N- to C-terminus) orientation of transmem-
brane GALA 30 is such that 26  3.5% of the peptide has
its N-terminus facing the outside of the liposome and 73 
6% of the peptide has its C-terminus facing the outside of
the liposome. As indicated earlier, the coherence of our data
implies that biotinylation has little influence on the head-
to-tail (N- to C-terminus) orientation of the peptide in the
bilayer. It is the amino-acids sequence that determines this
orientation and explains the higher tendency of the N-
terminus to insert into the bilayer.
TABLE 1 Percentage of GALA N-terminus and C-terminus
exposed on the external and internal side of POPC liposomes
at pH 5.0
GALA(N)1 GALA(N)2 GALA(C)2 GALA(C)3
100  R
(external)
26.5  3* 25.5  4 81  7 73  6
100  R
(internal)
74  5 71  5 N.D.# 33  7
Determination of r from Measurements Displayed in Fig. 4§
F0 2.73 2.75 2.77
F 2.37 2.59 2.58
F100 2.63 2.56 2.52
r 0.30 0.84 0.76
Determination of R from Measurements Displayed in Fig. 6¶
F0 5.35 4.51
F 4.95 4.65
F100 4.66 5.00
R 0.58 0.29
R 0.72 0.36
*Percentage of membrane-bound biotinylated GALA that bound to
BODIPY-avidin at pH 5.0 when the protein was either added in the
external medium of the POPC liposomes/peptides solution (100  R) or
pre-encapsulated in POPC liposomes (100  R). Values reported are based
on the average of n  3 to 6 determinations of R and R. GALA(N)
peptides are biotinylated at the N-terminus and GALA(C) peptides are
biotinylated at the C-terminus. Experiments to determine R and R were
performed with 2.5 mM and 0.65 mM POPC concentrations, respectively.
We used a lipid/total membrane-bound peptide molar ratio of 2500, a
BODIPY-avidin binding site/biotinylated GALA molar ratio of 8, and a
GALA 30/biotinylated GALA molar ratio of 19 and 14 for R and R
determinations, respectively.
#N.D.  not determined.
§Fluorescence intensities F0, F, and F100 and intermediate parameter r 
(F0  F)/(F0  F100)  (R/Z) determined from measurements displayed
in Fig. 4 and required to calculate R.
¶Fluorescence intensities F0, F, and F100 and intermediate parameter R 
(F0  F)/(F0  F100)  (R  0.8) determined from measurements
displayed in Fig. 6 and required to calculate R.
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Determination of GALA head-to-tail (N- to C-
terminus) orientation in POPC vesicles at pH 5.0
by the pre-encapsulation of BODIPY-avidin
If all the GALA peptides are oriented perpendicularly to the
membrane surface, an appreciable fraction of the N-termini
(1  RN  0.74) and the C-termini (1  RN  0.27) should
be exposed to the internal side of the liposomes. To verify
that the biotinylated peptides are transmembrane at a lipid/
membrane-bound peptide molar ratio of 2500/1, we deter-
mined the accessibility of the peptides biotin to BODIPY-
avidin pre-encapsulated in POPC liposomes. We used again
the differential enhancement of BODIPY-avidin fluores-
cence upon its irreversible binding to d-biotin or to a bio-
tinylated GALA to quantify the exposure of GALA’s biotin
to the internal side of the vesicle.
The assay comprised three independent measurements.
Each measurement yielded a fluorescence intensity required
to determine the internal exposure of GALA’s labeled ter-
minus. Measurements performed with the labeled peptides
GALA(N)1 and GALA(C)3 yielded traces like those shown
in Fig. 6 A and B, respectively, when a lipid/membrane-
bound peptide molar ratio of 2500/1, a lipid concentration of
0.65 mM [concentration at which80 mol% of the peptides
are membrane-bound (Nicol et al., 1996)], a GALA 30-to-
biotinylated GALA molar ratio of 14/1, and a BODIPY-
avidin binding site/biotinylated GALA molar ratio of 8 were
used. Measurements performed with GALA(N)2 resulted in
similar traces as those obtained with GALA(N)1.
In the three traces in which GALA(N)1 was used (Fig.
6 A), the initial intensity arose from the fluorescence of the
liposome-encapsulated BODIPY-avidin. The addition of
GALA 30 to the POPC liposome solution at pH 5.0 in the
control no exposure (Fig. 6 A, trace 1) did not alter
BODIPY-avidin fluorescence. The addition of GALA 30/
GALA(N)1 mixture in the internal layer exposure measure-
ment (trace 2) and the control total exposure (traces 3)
induced a partial dequenching of BODIPY-avidin fluores-
cence. This dequenching indicates that a significant fraction
of the membrane-bound biotinylated GALA peptides bound
to encapsulated BODIPY-avidin.
The addition of an excess of d-biotin, 15 min later, in the
control no exposure (Fig. 6 A, trace 1) and in the internal
layer exposure determination (trace 2), yielded a rapid
increase in BODIPY-avidin fluorescence. The extent of this
increase indicates that d-biotin translocated into the lipo-
somes and saturated the unoccupied BODIPY-avidin bind-
ing sites. D-biotin (244.3 MW) could translocate rapidly
through the membrane pores formed by GALA 30 or by the
mixture GALA 30/GALA(N)1. In the absence of peptide,
d-biotin permeated through the liposome bilayer at a much
slower rate (data not shown). The rapid translocation of
d-biotin was observed 15 min after the peptide had been
added to the POPC liposomes, which indicates that the
pores persisted for a long time.
The addition of d-biotin induced a larger dequenching of
BODIPY-avidin fluorescence in the control no exposure
(Fig. 6 A, trace 1) than in the internal layer exposure deter-
mination (trace 2). This difference was due to the partial
binding of GALA(N)1 to BODIPY-avidin in the internal
layer exposure (trace 2). The subsequent pH elevation to 8.0
and addition of the detergent C12E8 both enhanced
BODIPY-avidin fluorescence.
At the end of the control no exposure (Fig. 6 A, trace 1),
BODIPY-avidin binding sites were all occupied by a d-
biotin. A modification in the order of the addition steps did
not affect the final fluorescence intensity F0 (data not
shown). At the end of the internal layer exposure (trace 2),
only the fraction of membrane-bound biotinylated GA-
LA(N)1 that exposed its biotin tag on the internal side of the
liposomes at pH 5.0 was bound to a BODIPY-avidin bind-
ing site. Peptides that exposed their biotin tags on the
external side of the liposomes did not bind to BODIPY-
avidin. The BODIPY-avidin binding sites not occupied by a
labeled GALA were associated with a d-biotin. The final
fluorescence intensity was F.
For the control total exposure the steps following the
addition of the peptide mixture to the liposomes, i.e., the pH
increase and the subsequent addition of C12E8, led to the
complete binding of GALA(N)1 to BODIPY-avidin, which
explains the observed dequenching in BODIPY-avidin flu-
orescence (Fig. 6 A, trace 3). When d-biotin was added to
the solution 3 min later, the binding of d-biotin to the
unoccupied BODIPY-avidin binding sites induced a further
dequenching of BODIPY-avidin fluorescence. At the end of
the control total exposure (trace 3), all biotinylated GALA(N)1
were bound to a BODIPY-avidin binding site. The sites not
occupied by a labeled GALA(N)1 were associated with a
d-biotin. We verified that a modification in the order of the
addition steps did not affect the final fluorescence intensity,
F100, as long as d-biotin was added after all biotinylated GALA
bound to a BODIPY-avidin (data not shown).
From the three fluorescence intensities F, F100, and F0,
the fraction of membrane-bound GALA(N)1 peptide that
exposed its N-terminus on the internal side of the POPC
liposomes at pH 5.0, R, could be calculated (Eqs. 7–8).
We modified the protocol when the C-terminus-labeled
peptide GALA(C)3 was investigated and did not increase
the pH to 8.0 because of lack of sensitivity with this peptide
(Fig. 6 B). However, we believe that the determination of R
was still accurate at pH 5.0. Particularly, the presence of
C12E8 ensured a complete binding of the biotinylated pep-
tides to BODIPY-avidin in the control total exposure (trace
3). With GALA(N)1, the lack of pH elevation did not affect
R significantly (data not shown). We think this result is
extendible to the C-terminus-labeled GALA.
For the determination of R (external addition of
BODIPY-avidin), where F100, F and F0 were obtained at pH
8.0 without C12E8, F0 was higher than F100 with both
GALA(N)1 and GALA(C)3 (Fig. 4 A and C). Similarly, for
the determination of R, where F100, F, and F0 were ac-
quired in the presence of C12E8 at pH 8.0, F0 was higher
than F100 with GALA(N)1 (Fig. 6 A). However, in the case
of GALA(C)3, where F100, F, and F0 were obtained in the
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presence of C12E8 at pH 5.0, F100 was higher than F0 (Fig.
6 B). Thus, in this latter case, the binding of the C-terminus-
labeled GALA to BODIPY-avidin dequenched the fluores-
cence of the protein more than the binding of a d-biotin. We
attribute this difference to the location of the tryptophan of
the labeled GALA bound to BODIPY-avidin.
The fluorescence intensities F0, F, F100, the intermediate
parameter R, and R determined from the measurements
displayed in Fig. 6 are listed in Table 1, as well as the R
value determined from 3 to 6 sets of measurements with
GALA(N)1, GALA(N)2, or GALA(C)3.
The fact that we obtained RN (0.265) RN (0.74) 1 for
GALA(N)1 and RC (0.73)  RC (0.33)  1 for GALA(C)3
is compatible with a transmembrane orientation of all the
membrane-bound GALA peptides, at the lipid/peptide mo-
lar ratio of 2500/1 used in this study. We conclude that, on
average, GALA molecules are oriented in transmembrane
aggregates such that 74  5% of the peptide has its N-
terminus facing the inside of the liposome and 33  7% of
the peptide has its C-terminus facing the inside of the
liposome. This is compatible with the results found in the
assay with the external addition of BODIPY-avidin.
The binding of the biotinylated GALAs to BODIPY-
avidin in the internal side exposure experiment could par-
tially occur on the external side of the liposomes if there
was leakage of BODIPY-avidin in solution through the
GALA pores formed at pH 5.0. At a lipid/peptide molar
ratio of 2500/1, GALA pores are too small to allow the
permeation of vesicle-entrapped molecules such as
BODIPY-avidin (60,000 MW) (Nicol et al., 1996).
We demonstrated that, indeed, there is no leakage of
BODIPY-avidin from the vesicles at the 2500/1 ratio. In a
variation of the control no exposure, we raised the pH to 8.0
15 min after the addition of GALA 30 to the liposome
suspension at pH 5.0. This pH increase dissociated all the
peptides from the POPC bilayer. When we subsequently
added d-biotin, the fluorescence enhancement of liposome-
encapsulated BODIPY-avidin was slow and similar to the
case in which no peptide was included in the experiment.
This enhancement arose from the slow translocation of
d-biotin into the liposomes that occurred in the absence of
GALA pores. If a fraction of BODIPY-avidin had been
released in solution during the 15 min at pH 5.0, d-biotin
addition would have resulted in a rapid (1 sec) enhance-
ment of the fluorescence of the released BODIPY-avidin.
From the lack of rapid enhancement, in the presence or
absence of GALA, we could estimate that the percentage of
external BODIPY-avidin, with or without pores in the mem-
brane, was lower than the limit of detection of this assay and
less than 1% of the encapsulated material.
After the pH increase, the percentage of released
BODIPY-avidin was also determined by separation of the
vesicles from the released material on a Sepharose 4-B
column (1  15 cm). No fluorescent material was detected
in the fractions where free BODIPY-avidin would elute.
Thus, the observed BODIPY-avidin binding of the biotin-
ylated GALAs in the internal side exposure experiment
occurred only on the internal side of the vesicles.
Relationship between the external exposure of
GALA termini and the formation of
transmembrane aggregates
We suggest that an aggregate undergoes a transition be-
tween a surface state and a transmembrane configuration
when its size reaches a minimum number (M) of GALA
monomers. When the lipid/total peptide molar ratio is in-
creased, we expect GALA membrane aggregates to be
smaller because of the reduction in the average number of
peptides bound per liposome. Therefore, increasing the
lipid/total peptide ratio should reduce the fraction of pep-
tides that participate in transmembrane aggregates and in-
crease the fraction of peptides positioned parallel to the
bilayer surface. In the latter case, peptides expose both of
their termini to the external side of the bilayer, whereas the
inserted ones display only one terminus. Thus, the fraction
of biotinylated GALA that bind to BODIPY-avidin added to
the vesicle/peptides solution at pH 5.0 is expected to be
higher when the lipid/total peptide ratio is increased.
This is indeed the trend observed with the biotinylated
peptide GALA(N)1 (Table 2, first and second columns).
Measurements performed with GALA(N)1 are shown in
Fig. 7 A and B, for lipid/total peptide molar ratios of
20,000/1 and 40,000/1, respectively. Raising the lipid/total
peptide molar ratio from 7500/1 to 80,000 (Table 2) resulted
in a drastic increase of the fraction of GALA(N)1 N-termini
exposed on the external side of the liposome bilayer, as
indicated by an increase of RN from 0.285 to 0.91.
This tendency was also verified for GALA(C)3 C-termi-
nus, as evidenced by an increase of RC. At a lipid/total
peptide molar ratio of 40,000/1, we obtained RN RC 1.6
( 1), meaning that 60% of the membrane-bound peptides
exposed both termini on the outside of the vesicles and 40%
were inserted. These results imply that the fraction of pep-
tides oriented parallel to the membrane surface increased
when the average number of peptides per liposome decreased.
We demonstrated by the mathematical model developed
in greater details in Parente et al. (1990a), Rapaport et al.
(1996), and Nicol et al. (1996), that GALA 30-induced
leakage of ANTS/DPX from POPC liposomes at pH 5.0 is
only generated by the aggregates that comprise at leastM
10  2 peptides (Nicol et al., 1996). The peptides bind to
the liposomes, aggregate quasi-irreversibly, and form trans-
membrane pores. We used the same model to gain insight
into the transition of the peptides from lying parallel to the
bilayer surface to rearranging into a transmembrane orien-
tation. We tested the hypothesis that aggregates of a smaller
size (e.g., M  4, 6) than that needed for ANTS/DPX
leakage might be transmembrane. Equation 13 allows us to
calculate, for a particular value of M (minimum size of a
transmembrane aggregate) and a fixed lipid/peptide molar
ratio, the fraction of peptides that is involved in aggregates
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of size i, with i  M (Table 2, column 5). If we make the
assumptions that 1) in transmembrane aggregates (of size
i  M), the average fraction of membrane-bound GALA
peptides that exposes its N-terminus on the external side of
the liposome is 1⁄4, and 2) in surface aggregates (of size i 
M), every peptide exposes both termini to the external side,
the model can predict the percentage of GALA that exposes
its N-terminus (or C-terminus) on the external side of the
vesicles. Calculated values for M  4 and M  6 are
displayed in Table 2, columns 6 and 7, for various lipid/
peptide molar ratios. Experimental values of the percentage
of externally exposed N-termini (or C-termini) are displayed in
column 2 and 3. An interpretation of these calculated and
experimental results is given in the General Discussion.
GENERAL DISCUSSION
Applicability of the assay to determine the
orientation of GALA and other peptides
Finkelstein and coworkers have demonstrated the applica-
tion of the avidin–biotin interaction to provide information
on the transbilayer location of residues in membrane pro-
teins (Slatin et al., 1994; Qiu et al., 1994, 1996). These
studies showed that biotinylated residues not positioned in
the hydrophobic core of the membrane are accessible to
streptavidin binding. Based upon this precedent, we have
modified a fluorescent BODIPY-avidin/biotin binding assay
(Emans et al., 1995) to elucidate GALA 30 surface-ad-
sorbed or transbilayer orientation as well as the head-to-tail
(N- to C-terminus) orientation of the transbilayer GALA 30
in POPC liposomes at low pH. This assay can be applied to
other membrane-interacting peptides to determine their ori-
entation as well as to discern how rapidly they move across
bilayers or between membranes.
On examining the fluorescence change associated with
occupancy of the biotin binding sites of BODIPY-avidin, it
became apparent to us that a simple assay that merely looked
at the fluorescence increase associated with the binding of
liposome-bound biotinylated GALA to BODIPY-avidin at pH
5.0 was unable to quantify the extent of biotinylated GALA
binding to BODIPY-avidin because of a number of factors.
These include the low fluorescence increase of BODIPY flu-
orescence associated with the binding of BODIPY-avidin to a
membrane-bound biotinylated GALA at pH 5.0 and the im-
possibility to evaluate the fluorescence increase that would
arise from complete biotinylated GALA binding to BODIPY-
avidin in the exact same conditions. These factors led us to
assays that require three measurements in which multiple ad-
ditions of reagents are performed. Despite the complexity of
the assays, the difference between the three fluorescent deter-
minations is only due to the proportion of two populations of
BODIPY-avidin that are in the same environment. This situa-
tion permits a precise determination of biotinylated GALA
binding to BODIPY-avidin, and thus GALA orientation, in a
POPC bilayer at pH 5.0. It could be that, for other peptides, a
simpler assay based upon the fluorescence increase following
binding to the BODIPY-avidin would suffice for quantification
of peptide orientation. This was not the case for GALA.
BODIPY-avidin/biotinylated GALA binding assay
to determine GALA orientation in POPC vesicles
To study the orientation of GALA 30 in POPC bilayers at
pH 5.0 (the surface-adsorbed or transbilayer orientation as
TABLE 2 Relationship between the percentage of GALA N- (or C-)terminus exposed on the external side of a POPC bilayer, the
formation of transmembrane aggregates, and the leakage of ANTS/DPX by pore formation at pH 5.0
Lipid/peptide
molar ratio
N-terminus*
outside
(Exp., %)
C-terminus*
outside
(Exp., %)
Leakage of#
ANTS/DPX
(Exp., % (Cal., %))
Peptides in§
transmembrane
aggregates
(Calc., %,
M  4 (6))
N-terminus¶
outside
(Calc., %,
M  4 (6))
C-terminus¶
outside
(Calc., %,
M  4 (6))
80,000 91  7 N.D.** 1 (0.3) 14.4 (3.6) 89.2 (97.3) N.D.
40,000 71  6 89  8 13 (7) 47.4 (21.7) 64.5 (83.7) 88.2 (94.6)
20,000 46  6 N.D. 37 (32.2) 86.9 (64) 34.8 (52) 78.3 (84)
7,500 28.5  4 76  7 98 (94) 99.6 (98.9) 25.3 (25.8) 75.1 (75.3)
2,500 26.5  3 73  6 100 (99.1) 99.9 (99.7) 25 (25.2) 75 (75.1)
*Experimental values of N-terminus and C-terminus outside correspond to the percentage of membrane-bound GALA(N)1 and GALA(C)3, respectively,
that bound to BODIPY-avidin added to a POPC liposomes/peptides solution at pH 5.0 (100  R). Values reported are based on the average of n  3
determinations of R. We used a peptide mixture composed of GALA 30 and a biotinylated GALA (GALA(N)1 or GALA(C)3) at molar ratios of 19/1, 19/1,
9/1, 85/15, and 3/1, when lipid/total peptide molar ratios of 2500/1, 7500/1, 20,000/1, 40,000/1, and 80,000/1 were studied, respectively. The
BODIPY-avidin binding site/biotinylated GALA molar ratio was always 8.
#Extent of GALA 30-induced ANTS/DPX leakage measured at the plateau, which was obtained in less than 15 min after peptide addition to the POPC
vesicles. Calculated values are derived from the model described in Materials and Methods, taking M  10 and Ks  15 (Nicol et al., 1996).
§The percentage of peptides involved in transmembrane aggregates is determined as explained in Materials and Methods, assuming that only the aggregates
that contain M  4 (or M  6, value in parenthesis) or more peptides are transmembrane.
¶Calculated values of N-terminus and C-terminus outside are obtained from the percentage of peptides involved in transmembrane aggregates (column 5),
assuming that 1⁄4 of the transmembrane peptides exposed their N-termini on the external side of the bilayer, whereas the rest of them (3⁄4) expose their
C-termini. In surface aggregates (size i  4 (6)), all the peptides expose both termini on the external side of the vesicle bilayer.
**N.D.  not determined.
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well as the head-to-tail (N- to C-terminus) orientation of the
transbilayer peptide), we selected the biotin/avidin binding
as the basis of our assays. GALA 30 and its variants were
biotinylated and avidin was modified with BODIPY. These
labeled components were used in fluorescence-based deter-
minations of the percentage of biotinylated membrane-
bound peptides accessible for binding to BODIPY-avidin.
Biotin’s interaction with avidin is among the strongest non-
covalent affinities known (Ka  1015 M1). Thus, when a
BODIPY-avidin/biotin binding occurs, it should persist at
least for the time needed to determine the orientation of the
peptide in the membrane. We can also expect that an avidin-
bound biotinylated molecule would not exchange with an-
other biotin-containing molecule during this time frame.
A biotinylation reagent includes, at one end, the bicyclic
ring system necessary for binding to avidin and, at the other
FIGURE 7 Determination of R as a function of the lipid-to-total peptide molar ratio using the biotinylated peptide GALA(N)1. Traces were obtained by
monitoring the light emitted at   510 nm and following the protocol described in Materials and Methods. The legend is similar to that of Fig. 4, except
that the lipid-to-total peptide molar ratios used are (A) 20,000 and (B) 40,000 instead of 2500. At t  0, T2 and T3 refer to solutions at pH 5.0 that contain
POPC vesicles (2.5 mM lipid) and (A) a mixture of GALA 30/GALA(N)1 9/1 (total peptide concentration of 125 nM) or (B) a mixture of GALA
30/GALA(N)1 85/15 (total peptide concentration of 62.5 nM). The peptide mixture was replaced by nonbiotinylated GALA 30 at the same peptide
concentration as in T1. A BODIPY-avidin binding site/GALA(N)1 molar ratio of 8/1 and a d-biotin/BODIPY-avidin binding site molar ratio of 4/1 were
used in these experiments. The r ( R/Z) values of these particular sets of experiments were (A) 0.51 and (B) 0.73.
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end, a reactive functional moiety to couple with the target
group on the molecule to be labeled. A spacer arm is
included in between to extend the biotin group away from
the modified molecule, thus ensuring better interaction ca-
pability with avidin. In our assays, when the biotin moiety
attached to a membrane-bound GALA is exposed on the
external (or internal) side of the liposome bilayer, its spacer
arm must be long enough to allow binding of the bicyclic
ring system to BODIPY-avidin. The biotinylation reagents
used in this study to label GALA were selected to satisfy
this criterion. The original GALA sequence, GALA 30, was
labeled directly on the primary amine of the N-terminus
with Biotin-X/SE, yielding GALA(N)1, whereas the three
other labeling procedures were performed by coupling N-
(biotinoyl)N-(iodoacetyl)ethylenediamine to a cysteine on
a GALA 30 analog. GALA 31CN, which is GALA 30
elongated with a cysteine at the N-terminus, was labeled to
yield GALA(N)2. GALA 29CC and GALA 31CC, which
contain a cysteine at the C-terminus, were labeled to yield
GALA(C)2 and GALA(C)3, respectively. The two biotiny-
lation reagents selected for labeling, Biotin-X/SE and N-
(biotinoyl)N-(iodoacetyl)ethylenediamine, have suffi-
ciently long spacer arms (22.4 Å and 21.4 Å, respectively)
to bind to BODIPY-avidin.
In addition, to avoid changing the pore-forming proper-
ties of the peptide, biotinylation should not change consid-
erably its hydrophobicity. It is indeed the case, because
when we separated the biotinylated peptide from the unla-
beled peptide by HPLC on a C18 preparative column by the
solvent system: (A) water-0.1% TFA/(B) water-0.1% TFA,
the difference in elution corresponded to less than 4% B.
GALA forms a stable pore in bilayers
Unlike several natural cationic peptides for which transient
pores have been advocated to explain peptide-induced dye
release from liposomes [e.g., melittin, mastoparan, and ma-
gainin-2 (Rex and Schwarz, 1998; Matsuzaki et al., 1995,
1996, 1997a; Schwarz and Arbuzova, 1995)], GALA 30
forms stable pores in POPC, POPC/POPG, and egg PC
liposomes at pH 5.0. This statement is supported by Fourier
transform infrared studies (Goormaghtigh et al., 1991) and
by the finding that ANTS/DPX leakage proceeds through an
all-or-none mechanism (the permeabilized vesicles leak
their entire content of ANTS/DPX), with a very slow rate of
peptide transfer between membranes after insertion (Parente
et al., 1990a). Our current studies confirmed that GALA
forms stable pores in POPC large unilamellar vesicles at pH
5.0. When d-biotin molecules were added to the POPC
vesicles in the absence of the peptide at pH 5.0, they
exhibited a very slow penetration through the membrane,
whereas their addition at any time after peptide addition
resulted in rapid translocation. This result indicates that the
pores were still present at the time of d-biotin addition.
Furthermore, if the pores would undergo processes of for-
mation and destruction, then eventually all the membrane-
bound biotinylated peptides would be bound to BODIPY-
avidin molecules added externally or pre-encapsulated in
the vesicles. However, the fraction of labeled peptides
bound irreversibly to BODIPY-avidin in the internal layer
exposure and external layer exposure measurements did not
vary appreciably upon changing the time of incubation of
BODIPY-avidin with the liposome/peptides at pH 5.0 from
10 to 30 min, before the addition of d-biotin (data not
shown).
GALA orientation (surface-adsorbed or
transbilayer) in relation to pore formation
Our studies indicated that all the vesicle-bound GALAs
were involved in transmembrane aggregates at a lipid/pep-
tide molar ratio of 2500/1 and at pH 5.0, because one
terminus per peptide was displayed on each side of the
bilayer (RN  RC  1 and RN  RC  1 in Table 1).
Moreover, the fact that all the peptides displayed their
N-termini and their C-termini either on the external or the
internal side of the liposomes (RN RN 1 and RC RC
1 in Table 1) confirmed the transbilayer orientation of the
peptides. Thus, the percentage of peptide that exposed its N-
or C-terminus to both sides of the bilayer, in the time frame
of the measurements, was minimal. The fraction of peptides
that was buried in the bilayer core such that one of their
termini was inaccessible to BODIPY-avidin binding on
either side of the bilayer was also minimal. The fact that
almost 100% of the N-terminus or C-terminus biotinylated
peptides (Rtotal  0.96 for GALA(N)1 and Rtotal  0.98 for
GALA(C)3) bound to BODIPY-avidin when the protein
was, in the same measurement, pre-encapsulated and added
externally (data not shown), demonstrated the accessibility
of all the termini for binding to BODIPY-avidin at a lipid/
peptide molar ratio of 2500/1.
At lipid/total peptide molar ratios of 2500/1 and 7500/1,
where all the peptides are transmembrane and form or are
associated with pores, there was complete leakage of
ANTS/DPX (Table 2) and the fraction of GALA N-termini
exposed to the external side of the bilayer was similar
(0.265 and 0.285, respectively). This result suggests that a
fixed fraction (0.25) of the peptide that composed the
pores was oriented with its N-terminus exposed to the
external side of the membrane. The N-terminus predomi-
nantly resided on the inner side of the membrane (RN 
0.74 at a ratio of 2, 500/1).
We cannot determine from these measurements whether,
in all the pores, the helices are oriented in an alternating
fashion at a 3/1 N-terminus inside/N-terminus outside ratio,
or if 1⁄4 of the pores have all the helices with their N-
terminus outside and 3⁄4 of the pores have all the helices with
their N-terminus inside.
We demonstrated an increase in the fraction of peptide
that exposed its labeled terminus to the external side of the
vesicles when the lipid/peptide molar ratio was raised, i.e.,
under conditions at which pore formation and leakage of
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ANTS/DPX were reduced (Table 2). This result indicates
that the fraction of peptide that was positioned parallel to
the bilayer surface increased when the number of mem-
brane-bound peptides per vesicle decreased. At a ratio of
80,000/1, where little leakage of ANTS/DPX occurred, the
fraction of external N-terminus was increased to 0.91 (Table
2). The sensitivity of the assays makes the measurements
more difficult at very high lipid/total peptide molar ratios,
but the trend is that the fraction of the N-terminus exposed
to the external side of the membrane tends toward unity. A
similar evolution was observed with the C-terminus.
Additional details of the mechanisms of pore formation
by the amphipathic peptide GALA in POPC vesicles at pH
5.0 have emerged from the results obtained in this study.
Previously, Parente et al. (1990a) showed that the leakage of
ANTS/DPX requires pores consisting of at least M  10 
2 peptides. The calculations using Eq. 13 demonstrated that,
if we assume that surface aggregates become transmem-
brane when they reach a size of M  4 or 6 peptides, the
experimental values for the fraction of N-terminus exposed
on the external side of the membrane at various lipid-to-
peptide molar ratios could be explained (Table 2). Thus, the
model provided a consistent relationship between the ob-
served exposure of the termini and a putative transmem-
brane aggregate.
The emerging picture of the process of pore formation by
GALA in POPC vesicles at pH 5.0 is as follows. The initial
rapid binding of the peptide to the vesicle does not involve
a complete penetration of the peptide into the bilayer. The
peptides aggregate within the membrane at what we refer to
as the parallel orientation, resulting in both termini being
exposed to the external medium. When an aggregate has
reached a critical size (M  4 to 6), a rearrangement of the
peptides occurs, which leads to their rapid insertion into the
membrane and the formation of a transmembrane structure.
However, the aggregate apparently contains too few mono-
mers to form a pore that would allow the passage of ANTS/
DPX. If the bilayer contains sufficient peptides, the aggre-
gate can grow in size to 10  2 peptides to form a pore
through which ANTS/DPX can leak.
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